Tom Cole

3.5k citations
20 papers · 2.8k · 1 hit paper · h-index 15

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
  • Virology top 5%
    • HIV Research and Treatment

Papers in

Tom Cole

19 papers receiving 2.7k citations

Tom Cole's Hit Papers

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial 2020 · 1.9k citations
1.9k0+2+4Years since publication5001k1.5k

Peers

Tom Cole
Comparison fields: 5 of 106
  • Infectious Diseases 1.7k
  • Virology 152
  • Biotechnology 175
  • Microbiology 123
  • Immunology 190
Replace Boris S. Naroditsky with:
Boris S. Naroditsky Russia
Ian N. Moore United States
Catherine A. Cosgrove United Kingdom
Nita Patel United States
Laura Novik United States
Anthony Cook United States
Shirin Strohmeier United States
Eun Sung Yang United States
Tracy J. Ruckwardt United States
Holly A. Shelton United Kingdom
Tom Cole relative to Boris S. Naroditsky Russia Boris S. Naroditsky's profile →
Citations per field
00.5×2×3×4×4.9×
Boris S. Naroditsky · 1×
Citations per year

Countries citing papers authored by Tom Cole

Since Specialization
Citations

This map shows the geographic impact of Tom Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Cole more than expected).

Fields of papers citing papers by Tom Cole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Cole. The network helps show where Tom Cole may publish in the future.

Co-authors

The 25 scholars most cited alongside Tom Cole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom Cole Line = papers co-authored together Tom Cole links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Hit paper breakdown →
20201939
2 2015205
3 2019160
4 2021145
5 202170
6 201146
7 201038
8 202237
9 201631
10 201029
11 202426
12 201123
13 202223
14 201717
15 202217
16 201914
17 201810
18 20229
19 20252
20 20250

About Tom Cole

Tom Cole is a scholar working on Virology, Infectious Diseases, Microbiology, Biotechnology and Pharmaceutical Science, having authored 20 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Reproductive tract infections research (2 papers), Bacterial Infections and Vaccines (1 paper), Advanced Drug Delivery Systems (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Influenza Virus Research Studies (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (152 citations), Biotechnology (175 citations), Microbiology (123 citations) and Immunology (190 citations). Tom Cole has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robin J. Shattock, Leon R. McFarlane, Suzanne Day, Hannah M. Cheeseman, Max Per Kristiansen, Helene Bæk Juel, Karen Smith Korsholm, Morten Rühwald, Sonya Abraham and Peter Fibiger Bang. Their work appears in journals such as Vaccine, Frontiers in Immunology, PLoS ONE, EClinicalMedicine and EBioMedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact